Skip to content
Lower risk Drug recall · FDA · Published December 12, 2022

Lupin Rifampin Capsules Recall: Impurities Risk in Long-Term Storage

Lupin Pharmaceuticals recalls 300mg Rifampin capsules due to impurities detected during long-term stability testing. This may affect safety if stored beyond expiration.

🇺🇸 FDA recall #D-0100-2023DrugLupin ›
Take action

Contact the company

Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer

Lupin Pharmaceuticals is recalling 300mg Rifampin capsules that failed impurities testing during long-term stability studies. This could pose a risk if the medication is stored beyond its expiration date. Read more at govinfonow.com/recall/34189-lupin-rifampin-capsules-recall-impurities-risk-in-long-term-storage.

Source Summary by GovInfoNow · govinfonow.com/recall/34189-lupin-rifampin-capsules-recall-impurities-risk-in-long-term-storage · Updated August 18, 2026 · FDA enforcement record: FDA #D-0100-2023

Cite this page

“Lupin Rifampin Capsules Recall: Impurities Risk in Long-Term Storage.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34189-lupin-rifampin-capsules-recall-impurities-risk-in-long-term-storage. Based on FDA recall #D-0100-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0100-2023%22&limit=1).

Lupin Pharmaceuticals Inc. recalled Rifampin Capsules USP, 300 mg, 30-count bottles nationwide due to failed impurities and degradation specifications, the FDA said on Dec. 12, 2022. The voluntary Class II recall affects 16,056 units distributed across the U.S.

How to tell if you have it

  • Brand: Lupin
  • Product: Rifampin Capsules USP, 300 mg, 30-count bottle
  • NDC: 68180-659-06
  • Lot #: A200171
  • Expiration: 12/2023
  • Quantity: 16,056 bottles

The hazard

The recall was initiated because the product failed related substance testing during a long-term stability study, resulting in impurities or degradation specifications not being met. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Lupin Pharmaceuticals Inc. has had 90 other recalls on record since Jan. 31, 2013. Other recent recalls of similar products include Lupin Clobetasol Cream Recall (Aug. 3, 2026), Lupin Glucagon Emergency Kit Recall (June 23, 2026), and Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026). Other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection Recall (Feb. 4, 2026), Sun Pharmaceutical Lisdexamfetamine Capsules Recall (Oct. 28, 2025), and Amneal traMADol 50mg Tablets Recall (March 19, 2026).

How to tell if you have this one

Check for the product name 'Rifampin Capsules USP, 300 mg, 30-count bottle' with NDC 68180-659-06 and lot number A200171. The expiration date is December 2023.

  • Brand
    Lupin
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Expiration Date

    Verify the expiration date on the bottle label; if it's past December 2023, do not use the medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Dec 12, 202212. FDA classified it Class II: Jan 9, 202323. Published in FDA’s Enforcement Report: Jan 18, 202334. FDA terminated the recall: Jan 31, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Lupin recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0100-2023 (December 12, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0100-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA